1887

Abstract

Invasive aspergillosis is an emerging infection mainly affecting immunocompromised patients. This report details a case of tricuspid native valve endocarditis complicated by recurrent septic pulmonary emboli in a young, non-intravenous drug user. He was treated by surgical resection of the posterior leaflet of the tricuspid valve and the vegetations, as well as by valvuloplasty, which was followed by a combination of liposomal amphotericin B and voriconazole as acute-phase therapy and voriconazole alone as suppression therapy.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.46398-0
2006-05-01
2020-04-07
Loading full text...

Full text loading...

/deliver/fulltext/jmm/55/5/635.html?itemId=/content/journal/jmm/10.1099/jmm.0.46398-0&mimeType=html&fmt=ahah

References

  1. Abgueguen P., Gouello J. P., Pichard E., Chabasse D., Donal E., Alquier P. 2002; Candida endocarditis: retrospective study in 12 patients. Rev Med Interne 23:30–40 (in French [CrossRef]
    [Google Scholar]
  2. Bayer A. S., Scheld M. 2000; Endocarditis and intravascular infections. In Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases . , 5th edn. vol 1 pp  857–902 Edited by Mandell G. L., Bennett J. E., Dolin R. Philadelphia, PA: Churchill Livingstone;
  3. Chandrasekar P. H., Cutright J. L., Manavathu E. K. 2001; Aspergillus: rising frequency of clinical isolation and continued susceptibility to antifungal agents. Diagn Microbiol Infect Dis 41:211–214 [CrossRef]
    [Google Scholar]
  4. Karchmer A. W. 2000; Infections of prosthetic valves and intravascular devices. In Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases . , 5th edn. vol 1 pp  903–917 Edited by Mandell G. L., Bennett J. E., Dolin R. Philadelphia, PA: Churchill Livingstone;
  5. Li J. S., Sexton D. J., Mick N., Nettles R., Fowler V. G. Jr, Ryan T., Bashore T., Corey G. R. 2000; Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30:633–638 [CrossRef]
    [Google Scholar]
  6. MacCallum D. M., Whyte J. A., Odds F. C. 2005; Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis. Antimicrob Agents Chemother 49:3697–3701 [CrossRef]
    [Google Scholar]
  7. Marr K. 2004; Combination antifungal therapy: where are we now and where are we going?. Oncology 18 (Suppl. 7):S24–S29
    [Google Scholar]
  8. Maschmeyer G., Ruhnke M. 2004; Update on antifungal treatment of invasive Candida and Aspergillus infections. Mycoses 47:263–276 [CrossRef]
    [Google Scholar]
  9. Muehrcke D. D., Lytle B. W., Cosgrove D. M. III 1995; Surgical and long-term antifungal therapy for fungal prosthetic valve endocarditis. Ann Thorac Surg 60:538–543 [CrossRef]
    [Google Scholar]
  10. NCCLS 1998 Reference Method for Broth Dilution Antifungal Susceptibility Testing of Conidium-forming Filamentous Fungi: Proposed Standard . NCCLS document M38-P Wayne, PA: National Committee for Clinical Laboratory Standards;
    [Google Scholar]
  11. Pierrotti L. C., Baddour L. M. 2002; Fungal endocarditis, 1995–2000. Chest 122:302–310 [CrossRef]
    [Google Scholar]
  12. Rubinstein E., Noriega E. R., Simberkoff M. S., Rahal J. J. Jr (1974).Tissue penetration of amphotericin B in Candida endocarditis. Chest 66:376 [CrossRef]
    [Google Scholar]
  13. Rubinstein E., Noriega E. R., Simberkoff M. S., Holzman R., Rahal J. J. Jr 1975; Fungal endocarditis: analysis of 24 cases and review of the literature. Medicine 54:331–334
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.46398-0
Loading
/content/journal/jmm/10.1099/jmm.0.46398-0
Loading

Data & Media loading...

Most cited this month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error